2,617 Shares of Cencora, Inc. $COR Bought by M Holdings Securities Inc.

M Holdings Securities Inc. purchased a new position in Cencora, Inc. (NYSE:COR) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,617 shares of the company’s stock, valued at approximately $786,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Pinnacle Associates Ltd. raised its holdings in Cencora by 1.8% in the 3rd quarter. Pinnacle Associates Ltd. now owns 2,203 shares of the company’s stock valued at $662,000 after acquiring an additional 38 shares during the last quarter. Elmwood Wealth Management Inc. lifted its stake in Cencora by 0.9% in the 2nd quarter. Elmwood Wealth Management Inc. now owns 4,314 shares of the company’s stock worth $1,221,000 after purchasing an additional 40 shares in the last quarter. Signature Equity Partners LLC boosted its holdings in shares of Cencora by 4.6% during the 1st quarter. Signature Equity Partners LLC now owns 937 shares of the company’s stock worth $294,000 after purchasing an additional 41 shares during the last quarter. Mosley Wealth Management boosted its holdings in shares of Cencora by 11.5% during the 3rd quarter. Mosley Wealth Management now owns 407 shares of the company’s stock worth $122,000 after purchasing an additional 42 shares during the last quarter. Finally, Weaver Consulting Group boosted its holdings in shares of Cencora by 2.5% during the 3rd quarter. Weaver Consulting Group now owns 1,798 shares of the company’s stock worth $540,000 after purchasing an additional 44 shares during the last quarter. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Cencora news, EVP Elizabeth Campbell sold 11,300 shares of the company’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $324.12, for a total value of $3,662,556.00. Following the transaction, the executive vice president owned 19,455 shares of the company’s stock, valued at $6,305,754.60. This represents a 36.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.38% of the stock is owned by insiders.

Cencora Price Performance

NYSE:COR opened at $348.54 on Wednesday. Cencora, Inc. has a 52 week low of $244.82 and a 52 week high of $377.54. The company has a quick ratio of 0.59, a current ratio of 0.94 and a debt-to-equity ratio of 3.01. The company has a market capitalization of $66.51 billion, a P/E ratio of 19.45, a P/E/G ratio of 1.79 and a beta of 0.58. The stock’s fifty day moving average is $326.05 and its two-hundred day moving average is $317.23.

Cencora (NYSE:COR) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $4.66 EPS for the quarter, beating the consensus estimate of $4.58 by $0.08. The business had revenue of $88.35 billion for the quarter, compared to analyst estimates of $87.95 billion. Cencora had a return on equity of 110.72% and a net margin of 1.03%. The company’s quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $3.84 EPS. Equities analysts expect that Cencora, Inc. will post 19.58 EPS for the current year.

Cencora Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 30th. Investors of record on Friday, November 13th will be issued a $0.66 dividend. This is an increase from Cencora’s previous quarterly dividend of $0.60. The ex-dividend date is Friday, November 13th. This represents a $2.64 annualized dividend and a yield of 0.8%. Cencora’s payout ratio is presently 13.39%.

Analysts Set New Price Targets

COR has been the subject of a number of analyst reports. Royal Bank Of Canada restated a “sector perform” rating and issued a $330.00 price target on shares of Cencora in a research report on Tuesday, September 8th. Evercore reiterated an “outperform” rating and set a $350.00 price objective (up from $330.00) on shares of Cencora in a research report on Thursday, August 6th. Wall Street Zen raised Cencora from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Morgan Stanley raised their target price on Cencora from $346.00 to $377.00 and gave the stock an “overweight” rating in a research note on Friday, October 30th. Finally, JPMorgan Chase & Co. raised their target price on Cencora from $390.00 to $413.00 and gave the stock an “overweight” rating in a research note on Tuesday. Twelve equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $368.14.

Cencora Company Profile

Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical services company that connects pharmaceutical manufacturers with healthcare providers. Its core business includes sourcing and distributing medicines and other healthcare products to pharmacies, hospitals, health systems and other care providers. The company also provides services supporting specialty pharmaceuticals, including logistics, consulting and solutions for manufacturers and healthcare organizations. These services help manage the handling and delivery of complex medicines and support access to treatments.